|Mr. Erik Engstrom||CEO & Exec. Director||N/A||N/A||1963|
|Mr. Nicholas Lawrence Luff||CFO & Exec. Director||2.12M||N/A||1967|
|Mr. Rohinton Mobed||Chief Exec. Officer of Scientific, Technical & Medical||N/A||N/A||1960|
|Mr. Colin Tennant||Head of Investor Relations||N/A||N/A||N/A|
|Ms. Jans van der Woude||Legal Counsel & Company Sec.||N/A||N/A||1964|
RELX NV, through its interest in RELX Group plc, provides information and analytics for professional and business customers across industries worldwide. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment offers information and analytics to institutions and professionals. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry specific content with technology and analytics to evaluate and predict risk, as well as enhance operational efficiency. The Legal segment offers legal, regulatory, and business information and analytics. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier NV and changed its name to RELX NV in June 2015. RELX NV was incorporated in 1880 and is headquartered in Amsterdam, the Netherlands.
RELX NV’s ISS governance QualityScore as of 1 July 2018 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 3; Compensation: 1.